First South African developed HIV vaccines begin testing in Crossroads, Cape Town
South Africa has 36 participants from the Western Cape and Gauteng while the USA has already conducted trials on 12 participants.
Professor Anna-Lise Williamson, leader of the vaccine development team had this to say: “ An effective vaccine against HIV/ Aids remains a top global health priority and it is our hope that the evaluation of these vaccines in clinical trials will provide some important answers that will bring us closer towards this goal.”
